1-es típusú cukorbetegség: vizsgálatok itt: Lengyelország
17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Where
- Warsaw
- Életkor
- 1 év to 35 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00 - 3. fázisTaking peopleA Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Where
- Gdansk, Lodz, Warsaw, Wroclaw
- Életkor
- 1 év to 35 év
- People
- 300 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Bialystok, Cracow, Elblag, Gdynia, Katowice, Legnica, Lodz, Poznan, Radzionkow, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - No phaseTaking peopleClinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
- Where
- Gdansk, Krakow, Kraśnik, Lublin, Nadarzyn, Warsaw
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06704672 - 4. fázisTaking peopleAnti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A
- Where
- Lodz, Warsaw
- Életkor
- Up to 17 év
- People
- 2365 worldwide
- Run by
- Klinikum rechts der Isar der TU Muenchen AöR
See details and how to join2023-507348-35-00 · EU 2023-507348-35-00 - 3. fázisTaking peopleA Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Where
- Bialystok, Lodz, Lublin, Warsaw
- Életkor
- 1 év to 25 év
- People
- 723 worldwide
- Run by
- Sanofi
See details and how to joinNCT07088068 - 2. fázisTaking peopleSAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Where
- Opole, Poznan, Warsaw
- Életkor
- 5 év to 40 év
- People
- 159 worldwide
- Run by
- SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00 - 3. fázisTaking peopleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Bialystok, Białystok, Bydgoszcz, Cracow, Debica, Katowice, Poznan, Rzeszow, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - 3. fázisTaking peopleA trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
- Where
- Bialystok, Bydgoszcz, Cracow, Kielce, Lodz, Lublin, Poznan, Radom, Warsaw, Warszawa
- Életkor
- 18 év and over
- People
- 1010 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-524688-19-00 · EU 2025-524688-19-00 - 3. fázisTaking peopleAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Bialystok, Bolesławiec, Chorzów, Katowice, Libiąż, Lodz, Lublin, Olsztyn, Piotrkow Trybunalski, Poznan, Puławy, Rzeszow, Torun, Warsaw, Wroclaw, Zamość, Żyrardów
- Életkor
- 45 év and over
- People
- 1778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335 - No phaseTaking peopleINNODIA Family & Friends Early-Stage T1D Detection Protocol
- Where
- Katowice
- Életkor
- 1 év to 45 év
- People
- 30 000 worldwide
- Run by
- INNODIA iVZW
See details and how to joinNCT07118098 - 2. fázisTaking peopleTreatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody
- Where
- Bialystok, Gdansk, Katowice, Lodz, Lublin, Opole, Rzeszow, Szczecin, Warsaw, Wroclaw
- Életkor
- 3 év to 18 év
- People
- 150
- Run by
- PolTREG S.A.
See details and how to joinNCT06688331 · EU 2023-505226-33-00 - No phaseCsak meghívásosBody Composition, Fitness, and Thermoregulation in Young Boys With Type I Diabetes vs. Healthy Soccer Players
- Where
- Poznan
- Életkor
- 15 év to 17 év
- People
- 40
- Run by
- Paweł Korman
See details and how to joinNCT06676878 - No phaseNot yet taking people in LengyelországTime in rANge vs. Time in nOrmal Glycemia for Better Glycemic Control
- Where
- Warsaw
- Életkor
- 5 év to 18 év
- People
- 120 worldwide
- Run by
- University Hospital, Motol
See details and how to joinNCT07376850 - No phaseTaking people"Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin Therapy and Continuous Glucose Monitoring"
- Where
- Warsaw
- Életkor
- 18 év and over
- People
- 100
- Run by
- Medical University of Warsaw
See details and how to joinNCT07286500 - No phaseTaking peopleInsulin Therapy and Lipoproteins' Profile in Type 1 Diabetes.
- Where
- Poznan
- Életkor
- 18 év to 35 év
- People
- 300
- Run by
- Poznan University of Medical Sciences
See details and how to joinNCT02306005 - 2. fázisTaking peopleLisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes
- Where
- Gdansk, Katowice, Lodz, Opole, Warsaw
- Életkor
- 8 év to 198 hónap
- People
- 150
- Run by
- Medical University of Lodz
See details and how to joinNCT05957055 · EU 2023-506862-30-00